Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exagen Inc
(NQ:
XGN
)
2.980
-0.010 (-0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,417
Open
2.960
Bid (Size)
2.620 (1)
Ask (Size)
3.030 (4)
Prev. Close
2.990
Today's Range
2.910 - 3.080
52wk Range
1.300 - 3.710
Shares Outstanding
16,126,784
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Market Mayhem Winners: What Stocks Are Up Today?
August 05, 2024
What stocks are up today? It’s a natural question following the implosion of the global markets and the answer might surprise you.
Via
InvestorPlace
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+51.27%
+51.27%
1 Month
+46.08%
+46.08%
3 Month
+51.27%
+51.27%
6 Month
+56.84%
+56.84%
1 Year
+19.92%
+19.92%
More News
Read More
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
August 05, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 02, 2024
From
Exagen Inc.
Via
GlobeNewswire
Earnings Outlook For Exagen
March 15, 2024
Via
Benzinga
Exagen Inc. (NASDAQ: XGN) Near the Top of Equities by Percentage Gain on 1/29
January 29, 2024
Via
Investor Brand Network
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
August 01, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
July 22, 2024
From
Exagen Inc.
Via
GlobeNewswire
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
May 13, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Announces Campaign for Lupus Awareness Month
May 06, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce First Quarter 2024 Results on May 13, 2024
April 30, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Changes to the Board of Directors
April 26, 2024
From
Exagen Inc.
Via
GlobeNewswire
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023
March 18, 2024
Via
InvestorPlace
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
March 18, 2024
From
Exagen Inc.
Via
GlobeNewswire
Earnings Scheduled For March 18, 2024
March 18, 2024
Via
Benzinga
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 08, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
March 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2024
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 20, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.